Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 2

2(33.3%)

6Total

N/A(4)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07210255Not ApplicableRecruiting

SAINT in Postpartum Depression (PPD)

Role: lead

NCT07428460Not ApplicableRecruiting

Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

Role: collaborator

NCT05819021Active Not Recruiting

Open Label Optimization Study

Role: lead

NCT03693105Phase 2Terminated

The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition

Role: lead

NCT06462820Phase 2Terminated

SAINT for MDD in an Inpatient Setting Follow-on

Role: lead

NCT06523439Not ApplicableRecruiting

Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents

Role: collaborator

NCT05375214Not ApplicableCompleted

iTBS in Bipolar I Depression

Role: collaborator

All 7 trials loaded